1. Introduction {#s0005}
===============

Scientific search has shown that there is positive link between degenerative and/or neurodegenerative diseases and the excessive production of free radicals in human body ([@b0115], [@b0125]). Over the last twenty years, many literatures have been reported about the free radicals (nature and radix). To epitomize, free radicals are recognized as atoms/molecules with unpaired electrons that are able to create an unstable and highly reactive molecule. This unstable molecule can stabilize itself by taking an electron away from another stable molecule. Consequently, the stable one becomes damaged (a free radical), then a destructive chain reaction will build up, i.e. one radical generating another ([@b0080], [@b0045]).

Free radicals emit from the environment either from chain reactions of free radicals or from numerous ordinary biological processes, *in vivo*. Their reactions are started constantly in the body from enzymatic (those involved in cytochrome P450, phagocytosis and biosynthesis of prostaglandin) and non-enzymatic (those started by ionizing radiation) reactions ([@b0080], [@b0045], [@b0090]).

In human system, a fine biological balance between the ordinary physiological production of ROS/RNS and their removal is already existed. However, an excess of oxidative stress can lead to the oxidation of biomolecules, which is accompanied with cell damage and embroil in the pathogenesis of many human diseases ([@b0010], [@b0040]).

Antioxidants are very important substances elaborated in the body to counteract the ROS/RNS effects and inhibit the oxidative stress. They can be classified as enzymatic (those included glutaredoxin, glutathione reductase, SOD and catalase) and non-enzymatic (those included vitamin E, beta carotene, ascorbic acid, selenium, zinc and hypotaurine) ([@b0010], [@b0040]). Due to oxidative stress multifactorial pathogenesis and its involvement in a large number of lifestyle diseases like cardiovascular, cancer, diabetic and aging, the constant reassessment search was necessitated to adjust an appropriate strategy for designing and developing a potent antioxidant to protect the human body from the causative damage of free radicals ([@b0115], [@b0125], [@b0060], [@b0120], [@b0070], [@b0085]).

Recently, many heterocycles bearing triazole and/or quinazoline moiety were described as good antioxidant agents ([@b0060], [@b0070], [@b0085], [@b0075], [@b0105], [@b0110]). Furthermore, our triazoloquinazolines bearing hydrogen supplying, electron-donating and electron-rich moieties, were found to possess potential antioxidant properties ([@b0010]). Diversity in triazoloquinazoline and benzoquinazoline biological activities encouraged us to elaborate a new series of benzo\[*g*\]triazoloquinazolinones, which have demonstrated significant antimicrobial and anticancer activities ([@b0005], [@b0015]). In addition, the promising antioxidant results of our triazoloquinazolines ([@b0010]) provided us with some useful insights and thoughts about the required characteristics to design more active molecules against free radicals.

In view of the aforementioned facts and taking into account their similarities with our target compounds, we report herein the evaluation of the benzotriazoloquinazolines **1--16** as antioxidants using different assays.

2. Material and methods {#s0010}
=======================

2.1. DPPH assay {#s0015}
---------------

The antioxidant activity of benzotriazoloquinazolines was performed using DPPH free radical scavenging ([@b0055]). The prepared methanol solution of DPPH (20 μg/mL) was stored at 10 °C in the dark. The benzotriazoloquinazolines were dissolved in 85% methanol-water (v/v). Benzotriazoloquinazoline sample (0.5 mL) was added to DPPH solution (1.0 mL) and left to stir at RT. After 5 min incubation in the dark room, the absorbance was measured at 517 nm. The DPPH radical absorbance without antioxidant was measured also as control and used 95% methanol as blank. The obtained results were compared with blank control. All the determinations were performed in three replicates and averaged.$$\%\,\text{Scavenging}\,{\text{activity\ =}\mspace{6mu}}\left\lbrack {\left( {\text{control}\,\text{absorbance\ -\ sample\ absorbance}} \right)/{\text{control}\,\text{absorbance}}} \right\rbrack \times 100$$

Results were also presented as inhibition % of the DPPH radicals.

2.2. FRAP assay {#s0020}
---------------

A slight modification was carried out on Benzie and Strain protocol ([@b0050]). Three reagents were prepared; acetate buffer (300 mM, pH = 3.6), 20 mM FeCl~3~·6H~2~O solution and 10 mM TPTZ in 40 mM HCl. The FRAP was prepared freshly by mixing FeCl~3~·6H~2~O, acetate buffer and TPTZ in ratio of 2.5: 25: 2.5 (v/v/v), respectively. The mixture was warmed at 37^◦^C. In a dark condition, FRAP solution (2850 μL) was allowed to react with benzotriazoloquinazolines (150 μL) for 30 min. Measurement the absorbance readings of colored product (ferrous tripyridyltriazine complex) at 593 nm. The results are expressed in μmoLTrolox*/*100 g. The FRAP was calculated and when its measured value exceeded over the linear range of the standard curve, an extra additional dilution was applied.

2.3. RPC assay {#s0025}
--------------

In light to Oyaizu procedure, the benzotriazoloquinazolines reducing power was determined ([@b0100]). Potassium ferricyanide (1%) and phosphate buffer (0.2 M, pH = 6.6) were prepared. A solution of the sample (0.5 mL, 100 μg*/*mL) was added to the mixture of phosphate buffer (2.5 mL) and K~3~\[Fe(CN)~6~\] (2.5 mL). At a temperature of 50^◦^C, the mixture was incubated for 20 min, then centrifuged at 1000 r.p.m. for 10 min after aliquots of trichloroacetic acid (2.5 mL, 10%) were added. The mixture was allowed to separate into two layers. A solution of the upper layer (2.5 mL) was mixed with 0.1% FeCl~3~ (0.5 mL) and distilled water (2.5 mL). At 700 nm, the absorbance of the prepared mixture was measured. Increment in the reducing power indicated by increasing in the absorbance of the reaction mixture.

2.4. Density functional theory (DFT) calculations {#s0030}
-------------------------------------------------

Three main mechanisms have been proposed to explain the DPPH scavenging activity ([@b0025], [@b0030], [@b0035]) as following:(i)Proton Coupled-Electron Transfer (PC-ET) versus Hydrogen atom transfer (HAT)(ii)Electron Transfer-Proton Transfer (ET-PT)(iii)Sequential Proton Loss Electron Transfer (SPLET)

In the first mechanism, the N-H bond dissociation is hemolytic. Thus, the main parameter used to control such mechanism is called the bond dissociation enthalpy (BDE).

In this regards, the BDEs of compounds **1** and **14** are calculated using the following Eq. [(2)](#e0015){ref-type="disp-formula"}:where H is the enthalpy, H (An-H, 298 K) and H (An^•^, 298 K) are the enthalpies of parent products and their corresponding radicals, respectively; and H (H^•^, 298 K) is the enthalpy of hydrogen radical ([@b0010]).

BDE is an essential parameter that assess the capability of losing a hydrogen atom by molecule. Compound with a lower BDE, is the easier OH bond dissociation (i.e. potent antioxidant).

In the second mechanism, ET from the An-H to the free radical yields a radical cation An-H^+•^. Then, a heterolytic bond dissociation of the radical cation (i.e., proton loss) forms an An^•^ radical (Eq. [(3)](#e0020){ref-type="disp-formula"}). Ionization potential (IP) of the radical cation controls such mechanism. The lower IP value, is the easier electron transfer and the higher antioxidant activity.

Three steps are involved in the third mechanism (Eq. [(4)](#e0030){ref-type="disp-formula"}). Firstly, a heterolytic bond dissociation of a AnH group yields An^−^ anion and proton. Then, an ET from the An^−^ to the DPPH^•^ radical forms a An^•^ radical and DPPH^−^ anion. Finally, DPPH^−^ protonation forms DPPH~2~. A higher pH is favorable, which may help in the proton loss or transfer of the first step ([@b0065], [@b0095]).

Herein, the identification of the major mechanism that is involved in scavenging of DPPH radical and to rationalize of the higher antioxidant activity of **1** compared with **14** is carried out by calculation BDEs, IPs and DEs of both compounds.

The detailed DFT methods that described in our previous work ([@b0010]), are employed to determine all the quantum chemical as conformational analyses, optimization and frequency calculations.

3. Results and discussion {#s0035}
=========================

3.1. Antioxidant activity {#s0040}
-------------------------

[Scheme 1](#f0005){ref-type="fig"} illustrated the synthetic routes for the target benzotriazoloquinazolines **1--16** ([@b0020]). The diphenyl-*N*-cyanoimidocarbonate was reacted in basic medium with hydrazinonaphthoic acid in DMF and followed by treatment with Conc. HCl to give the parent (**1**). Reaction of **1** with alkyl(heteroalkyl) halides in DMF produced the targets **2--13**. Treatment of **1** with P~2~S~5~ in pyridine furnished the target **14**, which subsequently transformed into thioethers **15** and **16** by reaction with alkyl halides in basic medium ([@b0020]).Scheme 1The synthetic compounds **1**--**16.**

In this study, DPPH, FRAP and RPC assays were used to evaluate the *in vitro* antioxidant activity of compounds **1--16**. The standard synthetic antioxidant BHT was used.

The entire prepared benzotriazoloquinazolines **1--16** demonstrated different antioxidant activity. This activity was ranged from weak to high DPPH scavenging, reducing power and FRAP activities ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}), however, all derivatives were appeared less active than standard BHT. In accordance to the antioxidant results of triazoloquinazolines ([@b0010]), the targets **1--16** may be behaved the same behavior as redox agents, which can scavenge free radicals by reduction or donation of hydrogen atoms. DPPH is considered as a stable scavenger of free radical. It applied to assess the potential antiradical of antioxidants by quantify measurement the decrease in the absorbance of DPPH radical at 517 nm. DPPH in solution mode was deep violet color and when it gains the hydrogen or electron from the target antioxidant, it becomes pale yellow, which indicates decrease in the absorbance ([@b0010]). The antioxidant radical scavenging activity of the targets **1--16** was investigated at the same concentrations.Table 1DPPH scavenging activity of benzotriazoloquinazolines **1**--**16.**Samples (1 mg/ml)DPPH %**1**50.88 ± 0.15**2**29.88 ± 0.18**3**22.53 ± 0.21**4**16.63 ± 0.20**5**10.69 ± 0.18**6**16.79 ± 0.17**7**19.55 ± 0.13**8**20.12 ± 0.21**9**24.98 ± 0.10**10**14.24 ± 0.23**11**17.47 ± 0.14**12**20.57 ± 0.27**13**18.93 ± 0.15**14**36.01 ± 0.13**15**16.50 ± 0.13**16**27.16 ± 0.17**BHT**93[^1]Table 2FRAP of benzotriazoloquinazolines **1**--**16.**Samples (1 mg/ml)Antioxidant activity (µmol Trolox/100 g)**1**1376 ± 12.53**2**824 ± 8.19**3**951 ± 9.54**4**201 ± 8.62**5**265 ± 6.00**6**406 ± 6.24**7**203 ± 6.00**8**908 ± 13.01**9**440 ± 10.54**10**661 ± 8.00**11**752 ± 10.02**12**297 ± 6.03**13**946 ± 7.37**14**813 ± 5.86**15**720 ± 10.60**16**515 ± 6.11[^2]Table 3RPC of benzotriazoloquinazolines **1**--**16.**Samples (1 mg/ml)Absorbance at 700 nm**1**0.640 ± 0.014**2**0.361 ± 0.010**3**0.365 ± 0.014**4**0.181 ± 0.009**5**0.214 ± 0.006**6**0.202 ± 0.006**7**0.255 ± 0.011**8**0.344 ± 0.006**9**0.374 ± 0.010**10**0.184 ± 0.006**11**0.204 ± 0.003**12**0.252 ± 0.025**13**0.280 ± 0.011**14**0.396 ± 0.017**15**0.273 ± 0.025**16**0.345 ± 0.010**BHT**1.56[^3]

[Table 1](#t0005){ref-type="table"} presented the scavenging property of benzotriazoloquinazolines in terms of inhibition percent (at the same concentration as DPPH). The DPPH radical scavenging of benzo\[*g*\]triazoloquinazolines (**1** and **14**) showed the highest antioxidant activity in relation to the other derivatives, however, lower than BHT. Moreover, compounds **2**, **3**, **7**--**9**, **12**,**13**, and **16** exhibited moderate DPPH scavenging effects. Whereas **4**--**6**, **10**, **11** and **15** were emerged to have weak DPPH radical scavenging activity in relation to other derivatives and standard BHT at the same concentration ([Table 1](#t0005){ref-type="table"}). The pronounced activity of the targets **1** and **14** could be attributed to the presence of the lactam and thiolactam groups, respectively.

Concerning FRAP method, the targets depend on reducing ferric complex (Fe^3+^) in TPTZ into (Fe^2+^) that might be indirectly reflected the antioxidant capability. A very intense navy blue color was created due to binding of ligand with reduced iron (Fe^2+^). Measurement the absorbance determined the amount of Fe^2+^ ([@b0010]) and the FRAP results are summarized in [Table 2](#t0010){ref-type="table"}. In relation to trolox, compounds **1--3**, **8, 13** and **14** showed eminent FRAP activity. Their measured values ranged between 813 and 1376 (μmol Trolox/100 g). However, compounds **10**, **11**, **15**, and **16** emerged to have relatively moderate antioxidant activity, while **4**-**7**, **9** and **12** exhibited the lowest activity ([Table 2](#t0010){ref-type="table"}). For interpreting the compiled results in [Table 2](#t0010){ref-type="table"}, it is serious to realize that this method describes the capacity of the tested compound to share in one-electron redox reactions. The greatest in the antioxidant activity is a higher value of FRAP ([@b0010])

As presented in [Table 3](#t0015){ref-type="table"}, compounds **1** and **14** exhibited the highest reducing capacities in relation to other derivatives, however, they were less active than BHT. Compounds **2**, **3**, **8**, **9** and **16** showed the moderate effects, while compounds **4--7**, **10--13** and **15** demonstrated the lowest activity in regards to **1**, **14** and standard BHT. Variation in absorbance values is directly related to the total reducing power capacity of the antioxidant targets. The highest Fe^3+^ reduction ability of benzotriazoloquinazolines may be attributed to their inherited chemical features as electron donation or supplying hydrogen atom.

In light to the summarized findings in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, it can be concluded that the position of substituents and their types are the major determinants of the antioxidant characteristics of the benzotriazoloquinazolines. Moreover, their chemical features as electron donating or withdrawing effected DPPH scavenging activities. Consequently, the modification on the parent structure **1** afforded new derivatives (**2--16**) with a variety of antioxidant activity, however, they were appeared less active than their parent **1**. Thionation of **1** into **14**, was accompanied by slightly decrease in the antioxidant activity. However, further transformation of **14** into *S*-alkylated derivatives doesn't offer advantageous in the activity profiles. Similarly, alkylation of **1** into **2--13** doesn't show improvement in the antioxidant activity. Moreover, diversity in *N*-alkyl substituents resulted in variations of the activity, in which compounds **2** and **3** and **9** were found more active candidates among the *N*- alkylated compounds. Within this study, we noticed that the most active benzotriazoloquinazolines **1** and **14** are characterized by lactam and thiolactam functional groups, respectively. This may play a remarkable role in the activity profiles ([Scheme 2](#f0010){ref-type="fig"}).Scheme 2Plausible mechanism for the antioxidant activity of benzotriazloquinazolines **1** and **14.**

3.2. DFT study {#s0045}
--------------

On the basis of the percentage inhibition of DPPH free radical by compounds **1** and **14**, the former exhibited a strong antioxidant activity compared with latter ([Table 1](#t0005){ref-type="table"}). As can be seen from [Scheme 2](#f0010){ref-type="fig"}, the two compounds differ only by CO and CS groups. In order to explain the highest antioxidant activity of **1** (51%) comparable with **14** (36%), their corresponding IPs, BDEs and DEs of NH groups were calculated (see methods and materials section). Both compounds exhibited similar IPs with a difference less than 0.01 eV. Hence, ET-PT is not a favorable mechanism to scavenge DPPH free radical by **1** and **14**. Compound **1** exhibited a higher BDE value (96.3 kcal/mol) than **14** with a BDEs value of 90.8 kcal/mol. According to the obtained BDEs, the antioxidant activity of **1** is lower than **14**. However, these results are opposed to the experimental ones. In an attempt to understand the experimental results, DEs of **1** and **14** are calculated. Indeed, compound **1** showed a lower DE value of 285 kcal/mol compared with **14** (415 kcal/mol). The lower DE, the high antioxidant activity. This result is in good agreement with the experimental, and also confirms that the main mechanism that is involved in DPPH free radical is SPLET.

A plausible mechanism for the antioxidant activity of the active compounds **1** and **14** was illustrated in [Scheme 2](#f0010){ref-type="fig"} and confirmed by DFT study as sequential proton loss electron transfer (SPLET) mechanism, which included three steps as shown in material and methods part.

4. Conclusion {#s0050}
=============

The obtained results revealed that benzotriazoloquinazolines exhibited good antioxidant activities. The targets **1** and **14** showed the highest antioxidant effects. This can be attributed to the ability of the former to show a lower DE than the later. The SAR study of the tested compounds provided us with useful thought about the characteristic requirements to design more active compounds against free radicals. These requirements will be taken into consideration in the next foreseeable research.
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[^1]: Each value is expressed as mean ± SD (n = 3).

[^2]: Each value is expressed as mean ± SD (n = 3).

[^3]: Each value is expressed as mean ± SD (n = 3).
